Csf otic insufflation recalls
The FDA has published 1 recall involving Csf otic insufflation since 2022. The latest was reported on 2 Feb 2022. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2022
Last 12 months0reported
Class I00% of total
Ongoing0latest 2 Feb 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why csf otic insufflation is recalled
Companies
By year
All csf otic insufflation recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | CSF Otic Insufflation Capsule recalled by Edge Pharma | Edge Pharma | Manufacturing (CGMP) Deviations | Nationwide |
Should you stop taking Csf otic insufflation?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.